Baseline Reference Values for Concussion Assessments in Football
NCT ID: NCT05542628
Last Updated: 2024-10-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
2000 participants
OBSERVATIONAL
2021-01-01
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
All National Football Associations participating in The International Football Association Board's additional permanent substitutions trial are requested to provide baseline assessment data from players within their competitions
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Concussion Assessments in Football
NCT05713942
Heading in Football: Impact on Neural Blood Biomarkers
NCT06147596
Cerebral Blood Flow Regulation and Concussions
NCT02754206
The "Concussion or Brain Bleed" Trial
NCT04002505
The Effect of Intermittent Fasting on Acute Subconcussive Head Impacts
NCT05236127
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Diagnosing and determining the severity of a SRC immediately on- or off-field is challenging, especially because clinical signs can evolve after the mechanism of injury. Since combined injuries of the central and peripheral nervous systems are frequent, determining the locus of injury and therefore underlying explanation for symptoms is difficult and often not possible on- or off-field requiring a more focussed examination. Thus, the diagnosis and estimation of injury severity on- or off-field is a major challenge for the personnel performing an assessment. Nevertheless, an immediate, targeted assessment to support clinical decision-making is of great importance and helps to guide the management approach.
Current advice, when a player sustains a confirmed or suspected concussive injury, is to remove them from play immediately and not return to competition or unrestricted training until signs and symptoms have been managed as per relevant guidelines. Follow-up assessment of concussion incidents is recommended to include the Sport Concussion Assessment Tool 5th Edition (SCAT5). The SCAT5 is a standardized tool for use by healthcare professionals in the evaluation of individuals aged 13 years or older, who are suspected of having sustained an SRC. It comprises a neuropsychological test battery that assesses attention and memory function through 8 different domains. For further assessment of neurocognitive deficits and to inform return to play decisions, the Immediate Post-Concussion Assessment and Cognitive Testing tool version 4 (ImPACT) can also provide valuable information. The ImPACT is a computer-based neurocognitive test battery that provides an objective measure of neurocognitive functioning as an assessment aid in the management of concussed individuals aged 12-80 years.
Post-injury assessments can be compared to the player's assessment results from a non-concussed state (baseline assessment), adding more useful information to their interpretation. Unfortunately, many players do not have baseline assessments performed. Therefore, reference values from similar population groups can act as comparator to determine severity and progression of signs and/or symptoms. Reference values are reported in several sports, but values specific to football players are lacking.
The primary objective is to provide normal concussion assessment references values for use in football.
Our hypothesis is that there will be a variation of minor symptoms in non-concussed players.
Secondary objectives are to provide cumulative frequency distribution of the number of symptoms endorsed at baseline, as well as individual symptom endorsement. Additionally, we aim to provide an overview of cut-off scores and classification ranges to create a reference guide for clinicians of broadly normal and uncommon assessments. Where possible serial baseline assessments will be compared to confirm reliability.
The IFAB additional permanent substitutions trial is expected to run from January 2021 to August 2023 with potential for extension. All teams from participating competitions will be contacted and invited to participate if they have (or expect to) performed baseline assessments within the trial period. Contact information is gathered from the respective competition organisers.
The study is cross-sectional. There are no added procedures which participants have to undertake as being part of the study. The neurocognitive baseline assessments performed should already be a standard component of club practice, in line with international consensus guidelines. Normal practice is that baseline assessments are performed during the pre-season preparation period, at the time of contract commencement for a player entering a new club or one month after having been asymptomatic and medically cleared from a previous concussion injury. Other baseline demographic data will include playing position, age, sex and concussion history. The study will run for the same period as the trial. Early analysis of baseline data can be performed when all competitions have indicated their ability and willingness to participate in this study.
There is a risk of selection bias with potential higher representation of participants competitions with greater resources. To account for this, the study will accept data in any format to reduce the minor burden of participation.
Statistical analysis plan
Demographic data and baseline SCAT5 and ImPACT assessment results are summarized using descriptive statistics according to distribution to provide normal references values. Normal values will be calculated for men and women separately, and according to age, and number of previous concussions. Potential post hoc comparisons between sub-groups will be analysed using independent t-tests or Mann-Whitney U-test according to distributions, and the level of statistical significance will be set at p-value of \<0.05.
Sample-size calculation is not performed due to the exploratory study design. We aim to include all available data, but a target of participant data from 1000-2000 players is expected and considered to provide a relevant impression of normal reference values. Data will be analyzed separately for specific federations given sufficient representativeness.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention included
No intervention included
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Players without a current suspected or confirmed concussion
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Birmingham
OTHER
Federation Internationale de Football Association
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fèdèration Internationale de Football Association
Zurich, , Switzerland
The University of Birmingham
Birmingham, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.